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1. Introduction
   Hypertension is one the major public health problem 
worldwide[1]. Those individuals who are hypertensive are 
also at an increased risk for stroke, heart disease, and renal 
failure. Etiological factor related to essential hypertension 
has a genetic component but, lifestyle factors such as diet, 
sedentary habits, lack of exercise, smoking also have an 
impact in causation of hypertension[2]. In experimental 
studies, both human and animal models, Insulin resistance 
and glucose intolerance are most commonly observed 
phenomenon in relation to hypertension[3]. Increased 
reactive aldehyde, methylglyoxal is an aftermath of 
aberration in glucose metabolism[4]. Methylglyoxal binds 
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to both sulfhydryl and amino groups of proteins forming 
conjugates/advanced glycation end products. This disrupts 
protein structure and function furthermore can affect 
vascular calcium channels, enzymes, and tissue proteins 
leading to increased oxidative stress[2]. These alterations also 
impair endothelial functions with uninterrupted increase in 
intracellular free calcium, peripheral vascular resistance, 
and hypertension[5]. Even though it sounds simple, but the 
relationship between hypertension, oxidative stress and 
antioxidants is very complex and inadequately understood. 
Oxidative stress may play a role in the patho-physiology of 
hypertension as proved by experimental evidence but the 
same mechanism does not conform in humans. However it is 
suggested by research findings that in vivo oxidation of low-
density lipoproteins, primarily by oxygen-free radicals, may 
increase atherogenesis[6]. Hypertension associated long-
term infusion of angiotensin II is linked to the stimulation of 
oxidant production, leading to reduced bioactivity of NO and 
the activation of NAD(P)H oxidase[7].
   The relationship of hypertension with antioxidants and 
oxidative stress is therefore of much interest. Various 
scientific studies[8] have reported on the associations 
between antioxidants and cardiovascular disease, 
myocardial infarction and mortality, but fewer studies have 
focused on the relationship between antioxidant measures 
and hypertension. Even though, study suggested no concrete 
links and evidence of an association between blood pressure 
and intakes of either carotene or vitamin E, still mixed 
reports have come up where links between blood pressure 
and dietary antioxidants have been re-established. 
  Several studies have linked dietary supplementation with 
antioxidants rich vegetables and fruits including ascorbic 
acid, vitamin B1, B2 and B3 along with vitamin A and the 
quinone enzyme Q10 in decreasing blood pressure in animal 
models and humans with essential hypertension[9]. These 
antioxidants can act as potent antihypertensive agents 
by reducing aldehyde conjugate/advanced glycation end 
product formation and oxidative stress, by improving insulin 
resistance and endothelial function, or by normalizing 
calcium channels and peripheral vascular resistance[10]. 
   Study conducted among Australians has shown that the 
levels of antioxidants are lower and levels of uric acid and 
malondialdehyde are higher in hypertensive participants 
compared to normotensive participants[11]. So, dietary 
supplementation with antioxidants proves to be a beneficial, 
inexpensive, first-line alternate treatment modality for 
hypertension. It is reported that increased oxidative 
stress may be both a cause as well as a consequence of 
hypertension[12]. Based on in vivo experimental evidence it 
is shown that oxidized low-density lipoproteins (LDL) formed 
by oxygen-free radicals may increase hypertension-related 
atherogenesis, and antioxidants may be beneficial in this 
regard[9]. Previous findings concerning associations between 
serum measures of antioxidants and hypertension have 
however been inconsistent. 
   In the current study it is hypothesized that some significant 
association between serum levels of antioxidants and markers 
of oxidative stress with hypertension could be established.
2. Materials and methods
   Three hundred and forty five hypertensive participants 
and 345 age-sex matched normotensive healthy controls 
were taken for this study. The study was conducted for a 
period of three years from May 2007 to April 2010. The design 
of this study was pre-approved by the Institutional Ethical 
Committee Board of the institution and informed consent was 
obtained from the hypertensive participants and controls.
2.1. Cases
   Eligible cases with patients aged 56-64 year (201 men 
and 144 women) who were diagnosed of hypertension were 
recruited for the study. 
2.2. Controls
   For each case subject, 2 control subjects matched by 
age (within 5 years), sex, and hospital were obtained from 
outpatient clinics or inpatient wards. The study identified 
345 eligible control subjects. Controls were selected by 
using predominantly any of these two methods depending 
on the hospital. In the first method, we accompanied a 
particular physician during an outpatient clinic, according 
to a weekly schedule of clinics and wards. At the end of 
each consultation, the physician or the physician’s assistant 
invited the patient to speak with us about his or her lifestyle 
and diet. Patients matching the required age and sex profile 
were eligible according to study criteria and were then 
informed of the study and asked to participate. In these 
situations, participation was 100%. In the second method, we 
independently identified control patients from clinics and 
wards. We attempted to approach all individuals present in 
a particular outpatient clinic or in a specified ward. In large 
clinics, patients were screened for eligibility and invited to 
participate according to their queue number (highest number 
first). This method was used to prevent bias in the selection 
of controls. Overall participation was high (97%). Basic 
demographic information was collected from all persons who 
were approached. If an individual fit the required age and 
sex profile and was eligible, we briefly explained the study 
and asked whether the patient was willing to participate. 
Thus the study included 345 age-sex matched healthy 
volunteers (201 men and 144 women). 
2.3. Data collection 
   Interviews were conducted in hospital wards or clinics 
by us and lasted 30 min. Informed consent was obtained 
from all study subjects. The interviews included various 
life style factors such as education, socio-economic status, 
income and type of job. Details of major cardiovascular risk 
factors such as smoking, alcohol intake, diabetes, obesity 
and hypertension were obtained. We also collected data 
on socioeconomic status, smoking history, diabetes, and 
hypercholesterolemia, family history of cardiovascular 
disease (including ischaemic heart disease, angina, 
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myocardial infarction, hypertension, diabetes, stroke, 
sudden death, and bypass surgery), dietary intake, types of 
fat or oils used in cooking, nutritional supplement use, and 
physical activity. 
2.4. Dietary intake by 24-hour dietary record
   The patients and controls were given the food items 
which they were supposed to mark including the quantity 
consumed[13]. This was carried for three times in the same 
subjects to avoid biasness and to get more accuracy in 
intake. The dietary intake was tabulated and the amount of 
vitamins was calculated from the food consumed. 
2.5. Anthropometric measurements
   Anthropometric measures (height, weight, and hip and 
waist circumferences) were obtained and body mass index 
(weight in kg divided by height in meters squared) and 
waist-hip ratio were calculated. Their height, weight, waist-
hip ratio and blood pressure were recorded. Height was 
measured in centimeters and weight in kilograms using 
calibrated spring balance. Supine waist girth was measured 
at the level of umbilicus with a person breathing silently. 
Standing hip girth was measured at inter-trochanteric 
level. Waist and hip measures were assessed by using a 
standardized tape measure, with waist measures taken at the 
midpoint between the costal margin and ileac crest, and hip 
measures were taken at the widest circumference. 
2.6. Blood pressure
   The blood pressure was measured using standard mercury 
manometer. At least two readings at 5 min intervals as per 
World Health Organization guidelines were recorded[14]. 
If high blood pressure (曒140/90 mmHg) was noted a third 
reading was taken after 30 min. The lowest of the three 
readings was taken as blood pressure.
2.7. Collection of samples
   Blood (10 mL) was collected after overnight fasting in 
different containers.
   From EDTA vial, 5.0 mL of blood was taken. Red cells were 
washed 3-4 times with ice-cold normal saline and used for 
estimation of glutathione peroxidase, superoxide dismutase 
and catalase. 
   From plain vial, remaining blood was allowed to clot 
and serum was separated by centrifugation for 5 min at 
5000 r/min and was used for determination of lipid profile, 
malondialdehye and conjugated dienes, and other assays as 
described.
2.8. Lipid and serum profile measurements
2.8.1. Lipid profile
   Total cholesterol, triglycerides, and high density 
lipoprotein cholesterol (HDL-C) were estimated by enzymatic 
methods using the kits obtained from Randox Laboratories 
Limited, Crumlin, UK. Plasma LDL-cholesterol (LDL-C)was 
determined from the values of total cholesterol and HDL-
cholesterol using the following formulae:
                    T C-TG-HDL-C (mg/dL)
   LDL-C = 
                                        5
  All chemicals of analytical grade were obtained from Sigma 
Chemicals, India.
2.8.2. Serum albumin
  Serum albumin was measured by bromocresol green dye 
binding method[15]. 
2.8.3. Serum uric acid
  Serum uric acid was estimated by the method of Brown 
based on the development of a blue color due to tungsten 
blue as phosphotungstic acid is reduced by uric acid in 
alkaline medium[16].
2.8.4. Serum total bilirubin
   Serum total bilirubin was estimated by Jendrassik and Grof 
method[17]. 
2.8.5. Glutathione peroxidase
   The glutathione peroxidase activity was determined by the 
procedure of Paglia and Valentine[18]. 
2.8.6. Superoxide dismutase
   Superoxide dismuatse enzyme activity was measured by 
superoxide dismuatse assay kit using rate of inhibition of 
2-(4-indophenyl)-(4-nitrophenol)-5-phenyltetrazolium 
chloride reduction method modified by Sun et al[19]. 
2.8.7. Catalase
   Catalase activity was measured spectrophotometrically as 
described by Beutler[20,21].
2.8.8. Malondialdehyde
  Malondialdehyde levels were estimated by thiobarbituric 
acid reaction[22]. 
2.8.9. Conjugated dienes
   Conjugated dienes levels were measured by Recknagel 
and Glende method[23] with little modification. 
   All chemicals of analytical grade were obtained from 
Sigma Chemicals, India.
2.8.10. Lipoprotein (a)
   The lipoprotein (a) levels were determined by latex- 
enhanced turbidimetric method.
2.8.11. Ascorbic acid
   Estimation of vitamin C was carried out by Roe and 
Kuether method[24].  
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2.9. Statistical analysis
  Data was entered in Microsoft Excel for Windows 2007. The 
mean依SD was obtained using Excel software. The two-sample-
t-test value was obtained between the various hypertensive 
participants and the controls. The distribution of ‘t’-probability 
was calculated depending on ‘n’ and significance of the test was 
obtained. P value less than 0.05 was considered as significant.
3. Results
   Dietary vitamins intake was higher in hypertensive 
participants excepting for vitamin B2 and vitamin C which 
was higher in normotensive controls as shown in Table 
1. Anthropometric variables in hypertensive participants 
showed significant differences in weight, BMI, waist 
circumference, hip circumference, waist-hip ratio and mid-
Table 1
Mean dietary intake of vitamins in control and hypertensive participants (mean依SD).
Vitamins Normotensive (n=345) Hypertensive (n=345) P value (95% CI)
Vitamin A (毺g) 2208.7依158.3 2324.3依189.2           <0.01 (2290.86-2357.73)
Vitamin B1 (mg)   1.9依0.6   2.4依0.6 <0.05 (2.29-2.50)
Vitamin B2 (mg)   1.9依0.4   1.7依0.5  <0.01 (1.61-1.78)
Vitamin B3 (mg)   18.7依 2.7 22.8依5.2     <0.01 (21.91-22.08)
Vitamin C (mg) 445.7依82.8   387.6依123.8       <0.001 (365.72-409.47)
Table 2
Anthropometric data of normotensive and hypertensive participants (mean依SD).
Anthropometric variables Normotensive (n=345) Hypertensive (n=345) P value (95% CI)
Age (years)   59.93依3.2 61.07依3.14  0.0018 (60.51- 61.62)
Range (years)     (56-64) (56-64)
Height (m)     1.63依0.05    1.63依0.07 0.088 (1.61-1.64)
Weight (kg)    66.83依4.02  71.97依5.41    <0.01 (71.01-72.92)
BMI (kg/m2)    24.34依1.34   26.15依1.44    <0.01 (25.89-26.40)
Waist circumference (cm)    92.63依2.98 102.95依5.88      <0.01 (99.91-101.98)
Hip circumference (cm)    99.27依5.76 105.81依5.09        <0.01 (104.91-106.70)
Waist-hip ratio     0.93依0.03    0.95依0.03  <0.01 (0.94-0.95)
Mid arm circumference (cm)   27.67依1.62  30.62依1.98     <0.01 (30.02-31.21)
Biceps skin fold thickness (mm)     7.15依1.89    7.48依1.37 <0.001 (7.06-7.89)
Triceps skin fold thickness (mm)   10.93依1.36   12.92依1.66    <0.001 (12.41-13.42)
Systolic blood pressure (mmHg) 119.71依5.67   143.57依11.31       <0.001 (140.14-146.99)
Diastolic blood pressure (mmHg)   76.78依4.62   91.87依8.77    <0.001 (89.21-94.52)
Table 3
Lipid profile in normotensive and hypertensive participants (mean依SD).
Variables Normotensive (n=345) Hypertensive (n=345) P value (95% CI)
Total cholesterol (mg/dL) 156.67依17.69 196.36依17.68    <0.001 (193.23-199.48)
HDL-C (mg/dL) 54.35依5.59 39.38依5.73 <0.001 (38.36-40.39)
Triglycerides (mg/dL) 109.84依13.62 149.37依18.23    <0.001 (146.14-152.59)
LDL-C (mg/dL)  97.58依13.72 130.73依16.32    <0.001 (127.84-133.61)
Table 4
Antioxidant status in normotensive and hypertensive participants (mean依SD).
Serum parameters Normotensive (n=345) Hypertensive (n=345) P value (95% CI)
Serum albumin (g/dL)    4.6依0.5  4.8依0.4 <0.001 (4.72-4.87)
Serum uric acid (mg/dL)    5.6依1.7  4.9依0.7 <0.001 (4.77-5.02)
Serum ascorbic acid (mg/dL)    4.8依1.3  3.2依0.6 <0.001 (3.09-3.30)
Serum total bilirubin (mg/dL)    0.7依0.3  0.6依0.3  <0.01 (0.54-0.65)
Serum superoxide dismutase (U/gHb) 1769.5依28.4  756.5依197.6     <0.0 001 (721.57-791.42)
Serum glutathione peroxidase (U/gHb)   62.4依4.7 39.4依7.2  <0.0 001 (38.12-40.67)
Serum catalase (k/gHb)   248.3依22.6 213.4依38.2       <0.001 (206.64-220.15)
Table 5
Lipoprotein (a) and lipid peroxidation levels in normotensive and hypertensive participants (mean依SD). 
Normotensive(n=345) Hypertensive (n=345) P value (95% CI)
Serum Lipoprotein (a)(mg/dL) 2.6依1.3 12.8依3.1 <0.0 001 (12.25-13.34)
Serum malondialdehyde (nmol/L) 4.8依0.8 17.3依2.3 <0.0 001(16.89-17.70)
Serum conjugated dienes (毺mol/L) 23.3依3.2 53.7依4.7 <0.0 001(52.86-54.53)
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arm circumference whereas highly significant differences 
were observed in biceps and triceps skin fold thickness, 
systolic and diastolic blood pressure as shown in Table 2. 
The total cholesterol, LDL-C, triglyceride were significantly 
higher (P<0.001) in hypertensive participants except HDL-C 
which was significantly higher (P<0.001) in normotensive 
healthy controls as shown in Table 3. The serum endogenous 
antioxidants were significantly decreased in hypertensive 
participants except serum albumin levels compared to 
normotensive healthy controls. Also the enzyme antioxidants 
were also significantly lowered in hypertensive as shown in 
Table 4. The mean serum lipoprotein (a), malondialdehyde 
and conjugated diene levels in hypertensive participants 
were significantly higher (P<0.0 001) compared with controls 
as shown in Table 5. 
4. Discussion
  Hypertension remains the major risk factor for 
cardiovascular diseases which is the leading cause of 
morbidity and mortality in all developed and developing 
countries in the world including India[25]. Even though 
antioxidants and vitamins have antihypertensive effects 
by reducing oxidative stress and improving endothelial 
functions but still no clear results have been validated from 
researches. It is mentioned that dietary supplementation 
with antioxidants may prove to be beneficial and 
inexpensive and can be the best treatment modality for 
hypertension, but due to insignificant thumb print, still we 
are on the search of links between these two components 
and establish their association. In this hospital based study, 
the relationship between hypertension, antioxidants and 
oxidative stress in hypertensive participants in mid-adult 
life was examined. The study was designed to identify and 
evaluate potential link between the serum antioxidants, 
their dietary antioxidants intake (mainly from vitamins) with 
respect to hypertension. The subjects selected for the study 
comprised of 345 normotensive healthy controls, 56-64 year 
and 345 hypertensive participants, 56-64 year. 
4.1. Dietary antioxidants intake
   Of the dietary vitamins intake measured, the hypertensive 
participants had significantly higher consumption of 
vitamins A, B1 and B2 compared to normotensive healthy 
age-sex matched controls. The current study observed 
higher antioxidant vitamins consumption in hypertensive 
participants compared to normotensive healthy controls, 
excepting for vitamin C which was higher in controls. The 
matter of debate arises why the antioxidant status was 
comparatively lower in hypertensive participants compared 
to controls even though they had higher exogenous intake 
of antioxidants vitamins through the food stuffs. The basis 
could be partially explained with the nullifying effect of 
these vitamins by various inter-plays of oxidants and pro-
oxidants which could have been higher in hypertensive 
participants, making it failed to provide adequate protection 
from oxidants[26]. Earlier studies have emphasized to 
increase the antioxidants in diet and clinical trials have 
shown effective results. Though a beneficial role for vitamins 
in hypertension has long been explored but the data are 
still inconsistent[27], and it is not affirmative with several 
findings. 
   Extensive studies have been conducted on intake 
of vitamin C and it has been suggested by several 
epidemiological studies that vitamin C status inversely 
associated with blood pressure[28]. 
   Previous studies have reported that vitamin C level was 
lower in hypertensive patient, compared to the general 
population[29]. The observations from the current study 
conform with the previous studies. 
   Several mechanisms have been proposed in connection 
with reduction of blood pressure of an individual by 
increasing the vitamin C intakes through diet and also if 
their levels are higher in serum. The beneficial effects of 
vitamin C are well understood. It serves as a potent blood 
pressure stabilizer in normalizing the blood pressure, 
due to its antioxidant properties. As an antioxidant, it has 
enormous roles to play and it sustains a special function 
in maintenance of blood pressure by its interference with 
production of free oxygen radicals and peroxides and 
also stimulate the synthesis of prostaglandins such as 
prostacyclin, which is vasodilator in nature[30]. Apart from 
that, it also induces the release of norepinephrine from 
adrenal glands, which reduces the plasma level of sodium. 
Vitamin C is more than an antioxidant and its effects on 
neurotransmitters may contribute to its anti-hypertensive 
activity[31]. 
   Vitamin C not only enhances the nitric oxide synthase 
activity but also augments guanylate cyclase sensitivity 
to nitric oxide[32]. Last but not the least it may reduce 
insulin resistance which in turn causes endothelium-
dependent, nitric oxide-mediated vasodilation[33]. Apart 
from direct links in lowering hypertension, it also attenuates 
hypertension related conditions such as endothelial damage 
or arterial stiffness[34].
4.2. Anthropometric variables
   When the anthropometric variables were analyzed it was 
observed that there were highly significant differences in 
both biceps and triceps skin fold thickness in hypertensive 
participants when compared with normotensive controls. 
Earlier study conducted among elderly Malaysian also 
observed significantly higher anthropometric profile 
especially waist and hip circumference, waist to hip ratio 
and body mass index in hypertensive subjects as observed in 
the current study[34]. Another study conducted in Turkey on 
hypertensive subjects stressed on the clinical usefulness of 
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waist to hip ratio as a useful tool in screening obese patients 
with elevated blood pressure[35]. Yet another cross-sectional 
study among Brazilian men also observed similar findings as 
the current study[36]. They also reported significantly higher 
anthropometric profile in hypertensive subjects compared to 
normotensive controls but highlighted waist circumference 
as the only independent anthropometric measurement 
related to hypertension. Another study conducted on Turkish 
hypertensive adults also observed similar findings as the 
current study where they reported overweight, obese and 
waist circumference among hypertensive adults as important 
factors affecting both systolic and diastolic blood pressure in 
Turkish hypertensive adults[37].
   So from the observations made by most of the study 
in various countries, it is implicative of the fact that 
anthropometric profiles in hypertensive subjects are bound 
to be higher than normotensive subjects. It can be concluded 
from the aforementioned observations that obesity, 
waist circumference and waist to hip ratio are important 
observations in hypertensive subjects. 
4.3. Observations of lipid profile 
  The mean total cholesterol level of hypertensive 
participants [(196.36依17.68) mg/dL] was significantly (P<0.001) 
higher when compared with controls [(156.67依17.69) mg/
dL]. The mean high density lipoprotein-cholesterol level 
in the hypertensive [(39.38依5.73) mg/dL] was significantly 
lower (P<0.001) compared with normotensive controls [(54.35
依5.59) mg/dL]. Triglyceride values observed in hypertensive 
participants was [(149.37依18.23) mg/dL] significantly higher 
than controls [(109.84依13.62) mg/dL]. The mean LDL-C levels 
in hypertensive participants was [(130.73依16.32) mg/dL] 
significantly higher than controls [(97.58依13.72) mg/dL]. 
   Earlier studies carried out on forty hypertensive 
patients also observed a significantly higher levels of 
total cholesterol, triglyceride and LDL-C compared to 
normotensive controls[38]. 
   Yet another study carried out in Spain in hypertensive 
patients with dyslipidemia treated with lipid lowering 
therapy also observed a significantly higher levels of 
triglycerides and lower levels of HDL-C in hypertensive 
patients compared to normotensive controls. It was reported 
from the study that despite of treatment with lipid lowering 
drugs, the lipid profile in hypertensive patients remained 
on the higher levels when compared with controls and 
this could be area of concern as it could be a potent 
cardiovascular risk[39]. Even the study carried out among 
hypertensive Nigerians reported significantly elevated levels 
of total cholesterol, triglyceride and LDL-C but the levels of 
HDL-C were comparable with normotensive[40].
   Also studies conducted earlier among hypertensive 
subjects in Malaysia, Brazil and Turkey reported similar 
findings which concurred with the current study[34-37]. So it 
can be presumed that all hypertensive subjects have higher 
lipid profiles compared to normotensive.
4.4. Antioxidant status 
  The serum endogenous antioxidants namely albumin, 
uric acid, ascorbic acid, bilirubin showed varied results in 
hypertensive participants. The study observed higher serum 
albumin in hypertensive participant with a concomitant 
decrease in serum uric acid, ascorbic acid and bilirubin. 
The enzyme antioxidants namely superoxide dismutase, 
catalase and glutathione peroxidase were significantly 
lowered in hypertensive participants when compared with 
normotensive controls. 
  A population based cross-sectional study conducted in 
Norway observed a positive correlation with serum albumin 
concentration with hypertension and the current study 
also observed similar findings[41]. Though albumin is an 
antioxidant and is cardio protective in nature due to its free 
radical scavenging properties, it positively correlated with 
hypertension. Another study conducted at New Delhi on mild 
hypertension subjects observed the serum albumin levels 
drastically decreased in the hypertensive patients compared 
to healthy normotensive controls[42], and their findings does 
not concur with the current study.
   The current study observed significantly lower levels 
of uric acid in hypertensive participants when compared 
with normotensive controls. The findings of this study does 
not conform with the previous study report where they 
observed higher level of uric acid in hypertensive subjects 
and claimed it to be a potent risk factor in the patients, and 
further stressed on the use of allopurinol in lowering the 
incidence of hypertension[43]. 
   With respect to vitamin C, the current study observed 
significantly lowered levels in hypertensive participants and 
it is very much agreeable with the findings of the previously 
studies[44,45].  
   The bilirubin levels in hypertensive participants 
were slightly lower than the normotensive controls. It is 
well known that bilirubin, though end product of heme 
degradation, has antioxidant potential which is mediated 
by the inhibition of nicotinamide adenine dinucleotide 
phosphate-oxidase oxidase (NADPH)[46,47], a key source of 
oxidants in phagocytic and non-phagocytic cells, and of 
protein kinase C activity[47,48]. Several studies have been 
published showing the relation between serum bilirubin and 
oxidative stress-mediated diseases, including angiotensin 
II-mediated hypertension[49]. The lowered levels of bilirubin 
in hypertensive participants conform with the observations 
of previous studies[50] where they suggested bilirubin as 
a prognostic marker in pulmonary arterial hypertensive 
patients and demonstrated that hyperbilirubinemia is 
associated with advanced right heart failure and markedly 
reduces the chances of survival in patients.
   The current study observed that the antioxidant enzymes 
namely superoxide dismutase, glutathione peroxidase 
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and catalase were found to be significantly lowered in 
hypertensive participants when compared with normotensive 
controls. The findings of the current study conform to the 
previous studies conducted on the similar line[51-56]. A study 
based on elderly hypertensive patients who were on their 
usual anti-hypertensive drugs and to link their association 
with glutathione antioxidant defense system observed 
increased activities of glutathione peroxidase and reductase 
along with higher concentration of glutathione in treated 
hypertensive patients compared to healthy normotensive 
subjects. They concluded from their study that during 
medication alterations in activities are likely to be related 
to the effect of treatment of NO bioavailability[53]. In fact, 
antihypertensive drugs are proven to have antioxidants 
properties and they have ability to lower oxidative 
stress[53,57,58]. From the study it is also observed that the 
drastic elevation of glutathione levels is due to decreased 
oxidative stress caused by antihypertensive drugs or else it 
could be due to adaptive mechanisms to oxidative stress. 
Of many one of the mechanisms that ties antioxidant and 
antihypertensive properties can be decreased level of 
superoxide radical O2
•- when hypertensive patients are on 
anti-hypertensive drugs. This effect can be mediated by 
increased level of glutathione which is known to prevent 
platelet-derived growth factor-mediated production of 
reactive oxygen species by NADH/NADPH oxidase, which is 
considered to be the main source of vascular reactive oxygen 
species and O2
•- in particular[59-61]. Moreover, glutathione 
in reaction with peroxynitrite ONOO- forms S-nitrosothiols, 
which have the ability to inhibit NADPH oxidase[53,62-64]. 
Furthermore, S-nitrosothiols subsequently release NO over 
prolonged time, thus extend the half-life of NO many-fold 
and in consequence relax vascular tissue[53,65-67]. 
4.5. Lipoprotein (a) and lipid peroxidation 
  The mean serum lipoprotein (a), malondialdehyde and 
conjugated diene levels in hypertensive participants were 
higher when compared with controls. 
   Studies conducted earlier also observed similar findings as 
observed in the current study[26,68]. 
  Based on the observations, our study concludes that 
hypertension is caused due to interplay of several 
confounding factors namely anthropometry, lipid profile, 
depletion of endogenous antioxidants and rise in oxidative 
stress. 
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Comments 
Background
   Hypertension is one of the major public health 
problem worldwide. It is one of the major risk factor 
for cardiovascular disease. It is a cumulative effect of 
antioxidant and oxidant imbalance which could be additive 
risk in causing hypertensive. Apart from these, there 
could be various other parameters which can affect the 
blood pressure in an individual including the lipid profile, 
anthropometry, obesity, lipoprotein (a), etc. The current study 
was based on assessment of risk variables in hypertensive 
patients compared to normotensive. The author analyzed 
the vitamin intake from various dietary sources, along with 
anthropometric variables and risk factors which could 
be additive risk in hypertension. This study is done on 
analysis of various risk factors and their association with 
hypertensive and normotensive subjects.
  
Research frontiers
   The current study was done to analyze the various risk 
factors which could be associated with hypertension and it 
is first of its kind done working with various parameters and 
analyzing the additive risk associate with hypertension. No 
such study was done earlier.
Related reports
   No such reports have been published or reported earlier.
Innovations & breakthroughs
   The markers like lipoprotein (a), conjugated diene, and 
malondialdehyde are significantly higher in hypertensive 
along with concomitant decrease in the levels of antioxidants 
level in serum which could be associated with raised blood 
pressure. Also body mass index and obesity could be risk 
factors in these subjects with higher blood pressure. 
  
Applications
   Timely measurement of antioxidants and risk variable 
parameters could assess the extent of progression of 
additional risks in hypertensive subjects.
Peer review
   Over all the paper is very informative and gives very 
scientific information, which makes us to rethink on various 
aspects causing the higher blood pressure in subjects. This 
paper is written well with correlation of so many risk factors 
which could be additional causes of the extent of blood 
pressure changes apart from the ones published elsewhere. 
Further research could be initiated on extensive analysis of 
Arun Kumar/Asian Pac J Trop Biomed 2014; 4(Suppl 1): S189-S197S196
individual risk factors in a large number of subjects so that 
the relative risk could be stratified.
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